[VRDN] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
11-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -4.76%
YoY- -191.66%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 168 2,514 2,182 718 874 734 1,274 -28.63%
PBT -6,435 -8,896 -8,714 -7,312 -2,507 -2,562 -3,289 11.82%
Tax 33 204 361 102 0 0 0 -
NP -6,435 -8,896 -8,714 -7,312 -2,507 -2,562 -3,289 11.82%
Tax Rate - - - - - - - -
Total Cost 6,603 11,410 10,896 8,030 3,381 3,296 4,563 6.34%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -3,830.36 -353.86 -399.36 -1,018.38 -286.84 -349.05 -258.25 56.68%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -1.82 -4.31 -4.31 -5.12 -3.50 -4.94 -12.14 -27.09%
EPS Diluted -1.82 -4.31 -4.31 -5.12 -3.50 -4.94 -12.14 -27.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.